General Information
Novo Nordisk SUSTAIN 8 NN9535-4270
Efficacy and safety of semaglutide versus canagliflozin as add-on to metformin in subjects with type 2 diabetes.
| Protocol | NN9535-4270 |
|---|---|
| Identifier | |
| UID | f91b9e25-5efa-45d8-9b16-776be87d7229 |
| Status | Done - Archived |
| Phase | 3b |
| Category | Diabetes Type 2 |
| Launch Year | 2017 |
| NCT Number | - |
| Created | 2016-12-08 09:48 |
| Last Updated | 2016-12-08 09:48 |
Description
No description provided.
Comment
PCRS
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2017-04-28 | No |
| Enrollment Open | 2017-03-15 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2017-03-08 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2019-02-05 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Martinez, Gilbert | GJMartinez | No |
| Recruiter | Miss, Salomon | SMiss | No |
| Coordinator | Sandoval, Larry | LSandoval | No |
| Regulatory | Perez, Myrna | MPerez | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Novo Nordisk |
|---|---|
| Division | Novo Nordisk |
| Team | Novo Nordisk |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
